Pharmaceutical studies and practices
Pharmaceutical studies and practices is a research topic within Pediatrics, Perinatology and Child Health. Science Explorer counts 41k research works in it since 1950. 13.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the developmental pharmacology and pediatric drug use, including topics such as off-label drug use, adverse drug reactions, clinical trials, pediatric formulations, medication adherence, regulatory framework, and neonatal intensive care. It addresses the challenges and considerations specific to drug disposition, action, and therapy in infants and children.
- Pediatric Pharmacokinetics
- Off-Label Drug Use
- Adverse Drug Reactions
- Clinical Trials
- Pediatric Formulations
- Drug Development
- Population Pharmacokinetics
- Medication Adherence
- Regulatory Framework
- Neonatal Intensive Care
- Research works
- 41k fractional, since 1950
- In the world top 10%
- 5.8k per year above
- Top-10% rate
- 13.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pharmaceutical studies and practices research?
By volume, the United States and India publish the most (1.5k and 455 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 India 455 works
- 3 United Kingdom 419 works
- 4 France 270 works
- 5 Germany 267 works
- 6 Spain 242 works
- 7 China 193 works
- 8 Italy 174 works
- 9 Brazil 169 works
- 10 Canada 168 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pharmaceutical studies and practices research?
By volume in 2022–2025, United States Food and Drug Administration publishes the most Pharmaceutical studies and practices research, followed by University of North Carolina at Chapel Hill and Harvard University.
By volume, 2022–2025
- 1 United States Food and Drug AdministrationUnited States 21 works
- 2 University of North Carolina at Chapel HillUnited States 20 works
- 3 Harvard UniversityUnited States 20 works
- 4 Center for Drug Evaluation and ResearchUnited States 18 works
- 5 University College LondonUnited Kingdom 18 works
- 6 KU LeuvenBelgium 16 works
- 7 Hindu College of PharmacyIndia 14 works
- 8 Medizinische Hochschule HannoverGermany 14 works
- 9 InsermFrance 14 works
- 10 University of WashingtonUnited States 14 works
Who are the leading researchers in Pharmaceutical studies and practices?
The most-cited researchers publishing on Pharmaceutical studies and practices include Lisa Hartling.
- 1 Lisa Hartling Canada 5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pharmaceutical studies and practices research done?
The largest centres of Pharmaceutical studies and practices research in 2022–2025 are London (United Kingdom), Paris (France), New York (United States) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Silver Spring and Basel.
Largest cities, 2022–2025
Where it is the local speciality
- Silver SpringUS · 41.6 works36×
- BaselCH · 25.7 works7.4×
Location quotient: how much more of its research is in Pharmaceutical studies and practices than the world average.
Where is the best place to study Pharmaceutical studies and practices?
Among universities, judged by research, Medizinische Hochschule Hannover, Hindu College of Pharmacy and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medizinische Hochschule HannoverGermany | 57.9 | 5.8% | 11.9× | 14 | +214.3% |
| 2 | Hindu College of PharmacyIndia | 53.6 | 13.4% | 25.1× | 14 | +68.8% |
| 3 | Harvard UniversityUnited States | 53.3 | 30.5% | 2.9× | 20 | +29.7% |
| 4 | University College LondonUnited Kingdom | 44.8 | 18.1% | 2.5× | 18 | +59.5% |
| 5 | KU LeuvenBelgium | 43.7 | 21.2% | 3.4× | 16 | -1.2% |
| 6 | University of WashingtonUnited States | 41.7 | 29.7% | 2.4× | 14 | +40.4% |
| 7 | University of LiverpoolUnited Kingdom | 41.7 | 20.2% | 4.4× | 12 | +40.7% |
| 8 | London South Bank UniversityUnited Kingdom | 41.5 | 0.0% | 32.7× | 10 | — |
| 9 | University of North Carolina at Chapel HillUnited States | 36.1 | 9.9% | 2.2× | 20 | +82.1% |
| 10 | University of California, San FranciscoUnited States | 34.9 | 15.7% | 3.9× | 13 | +24.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pharmaceutical studies and practices research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Pharmaceutical studies and practices.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.